TOK-8801
TOK-8801 is a synthesized dihydroimidazothiazole carboxamide and is under development as an immunomodulator.
Product Specifications
CAS Number
[105963-46-0]
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/TOK-8801.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(C)N2C(S1)=NC(C)(C)C2)NCCC3=CC=CC=C3
Molecular Formula
C17H21N3OS
Molecular Weight
315.43
References & Citations
[1]Fujiwara M, et al. Immunomodulatory activity of the newly synthesized compound TOK-8801 (N- (2-phenylethyl) -3,6,6-trimethyl-5,6-dihydroimidazo[2,1-b]thiazole-2- carboxamide) . Jpn J Pharmacol. 1989 Dec;51 (4) :549-54.|[2]Shibata K, et al. Immunomodulatory effect of a newly synthesized compound, TOK-8801 (N- (2-phenylethyl) -3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type hypersensitivity in mice. Int J Immunopharmacol. 1990;12 (5) :497-502.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-100162/TOK-8801-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-100162/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1212011 Inquire
Recombinant Saccharomyces cerevisiae N-alpha-acetyltransferase, 35 NatC auxiliary subunit (MAK10) , partial
Ask
View Details 
